Nootropics Index - Save on smarter supplements
Nootropics>Botanical & herbal supplements>Ashwagandha
Botanical & herbal supplements

Ashwagandha

Withania somnifera root / root extract

Ashwagandha (Withania somnifera) is a botanical root or root-extract supplement marketed for stress resilience, calm, and night-rest quality. Human evidence is most useful for short-term stress/rest outcomes, but trials are small, products vary, and direct nootropic claims are weaker than marketing often implies. Compare products by root versus root/leaf material, extract ratio, withanolide standardization, dose per serving, third-party testing, country-specific rules, liver/thyroid context, and sedating-stack context.

CalmRelaxationStress ResilienceMood SupportPhysical PerformanceHormone SupportHpa Axis Related
Updated October 2026/6 min read/9 citations
Reviewed by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
01

What is it?

Botanical root extract, not one single molecule

1

Ashwagandha is Withania somnifera, a botanical used in Ayurvedic practice and sold as powders, capsules, liquids, teas, and standardized extracts. Product labels may use root, root/leaf, extract-ratio, or withanolide-standardization language, which makes direct comparison harder than for a single chemical compound.

Best fit2
Compare root versus root/leaf material, extract ratio, withanolide percentage, dose per serving, COA availability, contaminant testing, country-specific rules, and whether claims stay within applicable food or supplement rules.

Stress/rest evidence is the strongest practical area

4

Systematic reviews find promising short-term signals for stress-tension and night-rest outcomes, but the evidence base is not large and studies use different extracts, doses, durations, and endpoints. This is a product-form-dependent signal, not a universal effect.

Cognition claims need restraint6
A recent meta-analysis reports cognitive-domain signals, but broad memory, focus, or mental-performance claims are not established. Product identity and study population remain important.
02

Names, aliases and forms

Common Namesashwagandha; Indian ginseng; winter cherry
Latin NameWithania somnifera
Traditional Nameashvagandha
03

Mechanisms of action

Stress biology and endocrine context

2

Mechanistic explanations often focus on stress-response pathways, cortisol, inflammatory signaling, and withanolide-rich extracts. These mechanisms help explain why the herb is studied, but they do not prove broad cognitive or productivity benefits.

04

Potential effects and evidence map

Systematic reviews report promising but limited short-term signals for stress-tension and night-rest outcomes, with small trial counts, varied extracts, and heterogeneous methods. Cognition and training-strength signals are product-, dose-, population-, and outcome-dependent, so broad focus, memory, or performance claims would be too strong for a comparison page. Safety evidence is less complete than benefit evidence, and comparison should account for liver, thyroid, pregnancy/lactation, sedating, and prescription-medicine context.

Effect domainMagnitudeGrade
Stress resilience4
CumulativeConfidence: Medium

Short-term adult trials show stress-tension score signals, but extract type, dose, and population differences limit certainty.

Note Use stress-resilience language, not disease-treatment or guaranteed calm claims.

3/5
B
Calm / relaxation4
CumulativeConfidence: Medium

Some users may notice calmer stress response over weeks, but the evidence is not a one-dose sedative guarantee.

Note Keep distinct from acute tranquilizer-style positioning.

2/5
B
Memory / learning6
CumulativeConfidence: Low

Recent meta-analysis reports cognitive-domain signals, but broad memory and focus claims remain product-form-dependent and not settled.

Note Avoid legacy-style broad cognition and mental-performance claims.

1/5
C
Physical energy / endurance6
CumulativeConfidence: Low

Training-strength signals appear in some adult trials, but they do not establish a general energy or performance product for every user.

Note Avoid broad performance marketing and compare extract identity first.

1/5
C
05

Typical dosages and timing

Typical
300-600 mg/day
Not a recommendation
Lower bound
300 mg/day
Profile value
Upper bound
600 mg/day
Profile value
common oral range5300-600 mg/day

A common comparison range is a few hundred milligrams per day of extract, but labels vary by extract ratio, withanolide standardization, and whether root or root/leaf material is used. Do not compare capsules by milligrams alone.

06

Timing & effect horizon

Effect horizonUnknown
Unknown
Study windows are usually weeks5

Sleep-trial durations in the cited review ranged from 6 to 12 weeks. This is a study window, not a single-dose effect duration or a recommended cycle.

Plasma timing is extract-dependent7

Human pharmacokinetic work found extract-dependent withanolide plasma time courses after a single dose. Plasma timing does not establish the timing of a subjective effect across products.

Acute measurements do not establish a general effect8

Acute trials have measured cognition, attention, fatigue, tension, or related markers over several hours after one preparation. That design does not establish a general same-day effect or a nootropic indication.

07

Safety, side effects and risk profile

Main safety filters before comparing prices1
For generally healthy adults, short-term use has been studied, but pregnancy/lactation, liver disease, thyroid or autoimmune conditions, upcoming surgery, sedative use, and relevant prescribed medicines need individual professional review. Rare liver-injury cases have been reported.
Liver / kidney caution3
Confidence: High

Rare cases link commercial ashwagandha products with clinically apparent liver injury; those reports do not provide an individual-product incidence estimate.

Note LiverTox advises avoiding use with cirrhosis or advanced chronic liver disease.

2/5
C
Pregnancy / lactation caution1
Confidence: High

NCCIH advises avoiding use during pregnancy and not using it while breastfeeding.

Note This is a population-specific safety filter, not a dose-adjustment recommendation.

2/5
B
Hormonal caution2
Confidence: Medium

Ashwagandha may matter for thyroid, cortisol, glucose, testosterone, autoimmune, and hormone-sensitive contexts.

Note NCCIH and BfR both flag endocrine or immune-system caution; thyroid case reports exist.

2/5
C
Sedation / impairment1
Confidence: Medium

Drowsiness can occur, and sedating stacks may impair driving, machinery, or next-day alertness.

Note Separate calming/rest positioning from impairment risk.

2/5
B
GI discomfort2
Confidence: High

Stomach upset, diarrhea, vomiting, headache, dizziness, rash, and drowsiness are practical tolerance issues reported by safety summaries.

Note Useful for product comparison and stop-and-review cues.

2/5
B
Legal / regulatory risk2
Confidence: Medium

Regulatory treatment differs by market; Germany BfR issued a 2024 caution for food supplements and says no safe intake guidance value could be derived.

Note Do not present one country-specific risk assessment as a global ban.

2/5
B
Evidence uncertainty1
Confidence: High

Benefit trials are generally short and use varied preparations; long-term safety remains uncertain.

Note NCCIH describes short-term use up to three months and does not support long-term conclusions.

2/5
B
GI, drowsiness, headache, dizziness, rash2stomach upset, diarrhea, vomiting, drowsiness, headache, dizziness, rash

BfR lists digestive upset, drowsiness, headache, dizziness, and rash as possible tolerance issues. Individual product composition can vary.

08

Legal and regulatory status

EU / GERMANY, AS OF 20242

In 2024, Germany's BfR said no safe intake guidance value could be derived for ashwagandha food supplements and identified groups requiring caution. Germany is an EU member state; this is a national risk communication, not an EU-wide or global legal classification.

09

Practical buying and quality notes

  • Compare root versus root/leaf material, extract ratio, withanolide percentage, and batch documentation; milligrams alone are not comparable across preparations.2
  • For powders and capsules, compare price per gram of labeled material, price per serving, withanolide percentage, extract ratio, plant part, batch COA, contaminant testing, country of sale, and whether claims stay within supplement/food rules.2
10

FAQ

Is Ashwagandha a nootropic?

6

Only in a limited, indirect sense. The best practical evidence is closer to stress/rest support than a strong direct focus, memory, or productivity effect.

What dose is typical?

5

A common comparison range is 300-600 mg/day of extract, but plant part, extract ratio, and withanolide standardization can change what that number means.

How long are studies usually?

5

Many adult trials run for several weeks, often around 8 weeks. That is a study window, not a recommended cycle or proof of long-term safety.

Who should avoid or get expert review first?

1

Pregnant or lactating users, children, people with liver disease history, thyroid or autoimmune disorders, upcoming surgery, hormone-sensitive prostate cancer context, sedative use, or relevant prescription medicines should get qualified review first rather than regard use as routine.

11

References

  1. National Center for Complementary and Integrative Health. Ashwagandha: Usefulness and Safety.
  2. German Federal Institute for Risk Assessment (BfR). Ashwagandha: food supplements with potential health risks. Communication 39/2024. 2024.
  3. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Ashwagandha. National Institute of Diabetes and Digestive and Kidney Diseases. Updated 2024.
  4. Fatima K, Malik J, Muskan F, Raza G, et al. Safety and efficacy of Withania somnifera for anxiety and insomnia: Systematic review and meta-analysis. Human Psychopharmacology. 2024.
  5. Cheah KL, Norhayati MN, Husniati Yaacob L, Abdul Rahman R. Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis. PLOS ONE. 2021.
  6. Zhu X, Zeng Q, Lei Y, Xu D, et al. Effects of Withania somnifera (L.) Dunal (Ashwagandha) on cognitive and physical function in adults: a systematic review and meta-analysis. Frontiers in Pharmacology. 2026.
  7. Vaidya VG, Naik NN, Ganu G, Parmar V, Jagtap S, Saste G, et al. Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis. Journal of Ethnopharmacology. 2024;322:117603.
  8. Xing Y, He R, Griffiths K, et al. Effects of Acute Ashwagandha Ingestion on Cognitive Function. International Journal of Environmental Research and Public Health. 2022;19(19):11852.
  9. Leonard MM, Edirisinghe I, Burton-Freeman B, et al. Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood. Nutrients. 2024;16(12):1813.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.